US5458874A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of increasing monocyte chemotaxis with CAP37 and monocyte chemotactic portions thereof
Assignee: Emory University
•
Filing: 1992-10-30
•
Granted: 1995-10-17
•
Expires: 2012-10-30
Abstract
Abstract Disclosed is a homogeneously pure monocyte chemotactic protein, CAP37, and the entire coding sequences for unprocessed and mature human CAP37 protein. Further, the recombinant production, from nucleic acid coding sequences, of mature CAP37 protein and the mature protein with amino-terminal and/or carboxy-terminal extensions is described. Also disclosed are methods to identify and recombinantly produce bioactive peptides derived from the CAP37 protein coding sequence which are effective chemoattractants monocytes and/or are capable of binding bacterial lipopolysaccharide. A method of preparing homogeneously pure CAP37 using hydrophobic HPLC is described. Bioactive peptide fragments of CAP37 having chemotactic, antibacterial and/or LPS-binding activity are disclosed. Finally, methods of treating wounds, diseased tissue, such as tumors, and infections are described.
Inventors
- 👤 Heloise A. Pereira
- 👤 John K. Spitznagel
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 04:03
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C07; C07K; C07K14/00; C07K14/435; C07K14/46; C07K14/47; C07K14/4701; C07K14/4723; C07K14/52; C07K16/00; C07K16/18; C07K16/24; A; A61; A61K; A61K38/00; C07K2319/00; C07K2319/20; C07K2319/23; C07K2319/50
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
74 words
A method for treating diseases involving monocyte localization or defects of monocyte chemotaxis which can be treated by increasing monocyte localization in an animal comprising the step of administering to said animal a therapeutic composition comprising a monocyte chemotactic amount of a monocyte chemotactic protein consisting of the amino acid sequence as defined in SEQ ID NO:9 or a monocyte chemotactic portion thereof, thereby treating diseases involving monocyte localization or defects of monocyte chemotaxis.
Claim 2
Independent Claim
74 words
A method for treating diseases involving monocyte localization or defects of monocyte chemotaxis which can be treated by increasing monocyte localization in an animal comprising the step of administering to said animal a therapeutic composition comprising a monocyte chemotactic amount of a monocyte chemotactic protein consisting of the amino acid sequence as defined in SEQ ID NO:9 or a monocyte chemotactic portion thereof, thereby treating diseases involving monocyte localization or defects of monocyte chemotaxis.
Claim 3
Independent Claim
79 words
A method for increasing the migration of monocytes to a particular tissue site, comprising the step of administering to said tissue site a therapeutic composition comprising a monocyte chemotactic protein consisting of the amino acid sequence as defined in SEQ ID NO:9 or a monocyte chemotactic portion thereof in a concentration to create a chemotactic gradient from the site of between 10 -8 M to 10 -11 M, thereby increasing the migration of monocytes to the particular tissue site.
Claim 4
Independent Claim
79 words
A method for increasing the migration of monocytes to a particular tissue site, comprising the step of administering to said tissue site a therapeutic composition comprising a monocyte chemotactic protein consisting of the amino acid sequence as defined in SEQ ID NO:9 or a monocyte chemotactic portion thereof in a concentration to create a chemotactic gradient from the site of between 10 -8 M to 10 -11 M, thereby increasing the migration of monocytes to the particular tissue site.
Claim 5
Independent Claim
59 words
A method of treating a wound which can be treated by increasing monocyte localization comprising the step of applying to said wound a topical medication comprising a wound treating and monocyte chemotactic amount of a monocyte chemotactic protein consisting of the amino acid sequence as defined in SEQ ID NO:9 or a chemotactic portion thereof, thereby treating the wound.
Claim 6
Independent Claim
59 words
A method of treating a wound which can be treated by increasing monocyte localization comprising the step of applying to said wound a topical medication comprising a wound treating and monocyte chemotactic amount of a monocyte chemotactic protein consisting of the amino acid sequence as defined in SEQ ID NO:9 or a chemotactic portion thereof, thereby treating the wound.
Claim 7
Dependent Claim
18 words
The method of claim 3, wherein the topical medication further comprises epidermal growth factor to promote wound healing.
References Cited (Backward Citations)
US4439199A
Cited
US4452735A
Cited
US4394443A
Cited
US4512971A
Cited
US4512970A
Cited
US4405601A
Cited
US4727028A
Cited
US4427660A
Cited
US4889919A
Cited
US5087569A
Cited
US5126257A
Cited
US5089274A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-10-16 | 1999-04-17 | 1999-10-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-10-16 | 2003-04-17 | 2003-10-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-10-16 | 2007-04-17 | 2007-10-17 | $7700.00 | Window Closed / Lapsed |